Literature DB >> 26267854

[Not Available].

J Fiehler1.   

Abstract

Mesh：

Year:  2015        PMID： 26267854     DOI： 10.1007/s00062-015-0434-7

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN： 1869-1439            Impact factor:   3.649


× No keyword cloud information.
  13 in total

Review 1.  Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICSS.

Authors:  Jens Fiehler; Søren Jacob Bakke; Andrew Clifton; Emmanuel Houdart; Olav Jansen; Daniel Rüfenacht; Michael Söderman; Christophe Cognard
Journal:  Neuroradiology       Date:  2010-05-04       Impact factor: 2.804

Review 2.  Factors influencing inclusion of patients with malignancies in clinical trials.

Authors:  Caroline Tournoux; Sandrine Katsahian; Sylvie Chevret; Vincent Levy
Journal:  Cancer       Date:  2006-01-15       Impact factor: 6.860

3.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

4.  Thrombectomy in patients ineligible for iv tPA (THRILL).

Authors:  Martin Bendszus; Götz Thomalla; Michael Knauth; Werner Hacke; Susanne Bonekamp; Jens Fiehler
Journal:  Int J Stroke       Date:  2015-06-04       Impact factor: 5.266

5.  Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.

Authors:  Osama O Zaidat; Brian-Fred Fitzsimmons; Britton Keith Woodward; Zhigang Wang; Monika Killer-Oberpfalzer; Ajay Wakhloo; Rishi Gupta; Howard Kirshner; J Thomas Megerian; James Lesko; Pamela Pitzer; Jandira Ramos; Alicia C Castonguay; Stanley Barnwell; Wade S Smith; Daryl R Gress
Journal:  JAMA       Date:  2015 Mar 24-31       Impact factor: 56.272

6.  Differences in complication rates among the centres in the SPACE study.

Authors:  Jens Fiehler; Olav Jansen; Jürgen Berger; Hans-Henning Eckstein; Peter A Ringleb; Robert Stingele
Journal:  Neuroradiology       Date:  2008-09-23       Impact factor: 2.804

Review 7.  Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.

Authors:  Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2013-11-27       Impact factor: 44.182

8.  Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study.

Authors:  Robert Stingele; Jürgen Berger; Karsten Alfke; Hans-Henning Eckstein; Gustav Fraedrich; Jens Allenberg; Marius Hartmann; Peter A Ringleb; Jens Fiehler; H Bruckmann; M Hennerici; O Jansen; G Klein; A Kunze; P Marx; K Niederkorn; W Schmiedt; L Solymosi; H Zeumer; W Hacke
Journal:  Lancet Neurol       Date:  2008-01-31       Impact factor: 44.182

9.  Grading quality of evidence and strength of recommendations: a perspective.

Authors:  Mohammed T Ansari; Alexander Tsertsvadze; David Moher
Journal:  PLoS Med       Date:  2009-09-15       Impact factor: 11.069

10.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321
View more
  1 in total

1.  Intracranial Stenting in Germany : The Reimbursement Decision has been made, but the Scientific Debate Continues.

Authors:  Bernd Eckert
Journal:  Clin Neuroradiol       Date:  2016-12       Impact factor: 3.649
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.